Financial Comparison: National Research (NRCIA) vs. Senomyx (SNMX)

National Research (NASDAQ:NRCIA) and Senomyx (NASDAQ:SNMX) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, institutional ownership and profitability.

Dividends

National Research pays an annual dividend of $0.40 per share and has a dividend yield of 1.2%. Senomyx does not pay a dividend. National Research pays out 69.0% of its earnings in the form of a dividend.

Earnings & Valuation

This table compares National Research and Senomyx’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
National Research $117.56 million 6.99 $22.94 million $0.58 57.84
Senomyx $29.32 million 2.44 -$1.26 million ($0.03) -49.33

National Research has higher revenue and earnings than Senomyx. Senomyx is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

33.6% of National Research shares are held by institutional investors. Comparatively, 30.7% of Senomyx shares are held by institutional investors. 5.7% of National Research shares are held by insiders. Comparatively, 13.0% of Senomyx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

National Research has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Comparatively, Senomyx has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500.

Profitability

This table compares National Research and Senomyx’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
National Research 19.52% 27.45% 19.09%
Senomyx -9.11% -15.80% -10.48%

Analyst Ratings

This is a breakdown of recent ratings for National Research and Senomyx, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research 0 0 0 0 N/A
Senomyx 0 0 0 0 N/A

Summary

National Research beats Senomyx on 11 of the 13 factors compared between the two stocks.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. The company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions; and risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. It provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, hospice, and payer organizations. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.

About Senomyx

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply